Suppression of Myc oncogenic activity by nucleostemin haploinsufficiency.

Zwolinska, A K; Heagle Whiting, A; Beekman, C; Sedivy, J M; Marine, J-C

Zwolinska, A K; Heagle Whiting, A; Beekman, C; Sedivy, J M; Marine, J-C.

Affiliation

Zwolinska AK; Laboratory for Molecular Cancer Biology, Department of Biomedical Molecular Biology, VIB-UGent, Technologiepark, Ghent, Belgium.

Oncogene ; 31(28): 3311-21, 2012 Jul 12.

Article in En | MEDLINE | ID: mdl-22081066

Subject(s)

GTP-Binding Proteins/genetics; Haploinsufficiency; Nuclear Proteins/genetics; Oncogenes/genetics; Proto-Oncogene Proteins c-myc/genetics; Proto-Oncogene Proteins c-myc/metabolism; Animals; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Lymphoma/genetics; Lymphoma/pathology; Mice; Transcription, Genetic/genetics; Tumor Suppressor Protein p53/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oncogenes / Nuclear Proteins / Proto-Oncogene Proteins c-myc / GTP-Binding Proteins / Haploinsufficiency Limits: Animals / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2012 Document type: Article Affiliation country: Belgium

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google